How to deal with patients with high-risk CLL


E-session 682

Expert
Davide Rossi'
Group Leader Experimental Hematology
Institute of Oncology Research (IOR)
Bellinzona, Switzerland
Discussant
Gianluca Gaidano'
Director, Division of Hematology
University of Eastern Piedmont
Novara, Italy

02
Nov 2023

With an unrestricted grant from